NYTech
People
Personemployee

Myrtle Potter

Board Chair and Director at Opentrons Labworks Inc.

LinkedIn profile Suggest an update

Overview

Myrtle Potter serves as Board Chair and Director at Opentrons Labworks Inc.[1][4] Potter is a biopharmaceutical executive and board director with experience building and scaling global organizations in the biopharma and diagnostics sectors.[2] Potter's recent executive roles include President, CEO and Chair of the Board of Sumitomo Pharma America and CEO of Sumitovant Biopharma.[2][8][9] Currently, Potter holds positions as Independent Director at Guardant Health and Founder & CEO of Myrtle Potter & Company, LLC.[3][5] Potter previously served as Independent Director at Ginkgo Bioworks, Inc. and held the position of Vant Operating Chair at Roivant Pharma.[7][10] Potter earned a Bachelor of Arts degree from the University of Chicago.[11]

Profile introduction
Source excerptLinkedIn [2]

I am a biopharmaceutical executive, board director, and advisor with a track record of building billion-dollar global biopharma companies and scaling global organizations at moments of transformative change. I am passionate about leveraging AI and robotics as business accelerators in biopharma and disease diagnostics sectors to improve patient outcomes and drive long-term value creation. Most recently, I served as President, CEO and Chair of the Board of Sumitomo Pharma America, Chair of the Board of Sumitomo Pharma UK, and CEO of Sumitovant Biopharma. In these roles, I led fast-growing, mult…

Career history

  1. Independent DirectorOct 2021 to presentGuardant Health
  2. Board Chair and DirectorMay 2021 to presentOpentrons Labworks Inc.
  3. Founder & CEOApr 2024 to presentMyrtle Potter & Company, LLC
  4. Independent DirectorApr 2013 to Apr 2026Liberty Mutual Insurance
  5. Independent DirectorJun 2024 to Jun 2025Ginkgo Bioworks, Inc.
  6. Chief Executive Officer, President and Chair of Sumitomo Pharma AmericaJul 2023 to Apr 2024Sumitomo Pharma America
  7. Chief Executive OfficerDec 2019 to Jul 2023Sumitovant Biopharma, Inc.
  8. Vant Operating Chair, Roivant PharmaJul 2018 to Dec 2019Roivant Sciences

Education

  1. Bachelor of Arts (B.A.)1976 - 1980University of Chicago
  2. Mayfield High School1973 - 1976

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.